Immix rises after new mid-stage trial data for AL amyloidosis therapy

Chinese EV maker BYD continues to make aggressive plans for Europe

2026/10/12

Jiuzi Holdings announces strategic investor commitment of $50M

2026/10/12

Harmony Biosciences appoints Peter Anastasiou as CEO

2026/10/12

Bausch + Lomb names Thomas Appio interim CEO, signals guidance hike

2026/10/12